An immunohistochemical evaluation of c-kit (CD-117) expression in malignant melanoma, and results of imatinib mesylate (Gleevec) therapy in three patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples